Design, synthesis, and evaluation of 5'-diphenyl nucleoside analogues as inhibitors of the Plasmodium falciparum dUTPase.

Abstract:

:Deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) is a potential drug target for malaria. We previously reported some 5'-tritylated deoxyuridine analogues (both cyclic and acyclic) as selective inhibitors of the Plasmodium falciparum dUTPase. Modelling studies indicated that it might be possible to replace the trityl group with a diphenyl moiety, as two of the phenyl groups are buried, whereas the third is exposed to solvent. Herein we report the synthesis and evaluation of some diphenyl analogues that have lower lipophilicity and molecular weight than the trityl lead compound. Co-crystal structures show that the diphenyl inhibitors bind in a similar manner to the corresponding trityl derivatives, with the two phenyl moieties occupying the predicted buried phenyl binding sites. The diphenyl compounds prepared show similar or slightly lower inhibition of PfdUTPase, and similar or weaker inhibition of parasite growth than the trityl compounds.

journal_name

ChemMedChem

journal_title

ChemMedChem

authors

Hampton SE,Baragaña B,Schipani A,Bosch-Navarrete C,Musso-Buendía JA,Recio E,Kaiser M,Whittingham JL,Roberts SM,Shevtsov M,Brannigan JA,Kahnberg P,Brun R,Wilson KS,González-Pacanowska D,Johansson NG,Gilbert IH

doi

10.1002/cmdc.201100255

subject

Has Abstract

pub_date

2011-10-04 00:00:00

pages

1816-31

issue

10

eissn

1860-7179

issn

1860-7187

journal_volume

6

pub_type

杂志文章
  • Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy.

    abstract::We developed new 10 B carriers for boron neutron capture therapy (BNCT) that can effectively transport and accumulate boron clusters into cells. These carriers consist of a lipopeptide, mercaptoundecahydrododecaborate (BSH), and a disulfide linker. The carriers were conceived according to the structure of pepducin, a ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800793

    authors: Isono A,Tsuji M,Sanada Y,Matsushita A,Masunaga S,Hirayama T,Nagasawa H

    更新日期:2019-04-17 00:00:00

  • Screening for the drug-phospholipid interaction: correlation to phospholipidosis.

    abstract::Phospholipid bilayers represent a complex, anisotropic environment fundamentally different from bulk oil or octanol, for instance. Even "simple" drug association to phospholipid bilayers can only be fully understood if the slab-of-hydrocarbon approach is abandoned and the complex, anisotropic properties of lipid bilay...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.200900052

    authors: Alakoskela JM,Vitovic P,Kinnunen PK

    更新日期:2009-08-01 00:00:00

  • Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based Methods.

    abstract::Aberrant WNT pathway activation, leading to nuclear accumulation of β-catenin, is a key oncogenic driver event. Mutations in the tumor suppressor gene APC lead to impaired proteasomal degradation of β-catenin and subsequent nuclear translocation. Restoring cellular degradation of β-catenin represents a potential thera...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000839

    authors: Kessler D,Mayer M,Zahn SK,Zeeb M,Wöhrle S,Bergner A,Bruchhaus J,Ciftci T,Dahmann G,Dettling M,Döbel S,Fuchs JE,Geist L,Hela W,Kofink C,Kousek R,Moser F,Puchner T,Rumpel K,Scharnweber M,Werni P,Wolkerstorfer B,

    更新日期:2020-12-04 00:00:00

  • Integration of Multiple Analytical and Computational Tools for the Discovery of High-Potency Enzyme Inhibitors from Herbal Medicines.

    abstract::Herbal medicines (HMs) are an important source of drugs. In this study, an efficient strategy integrating ultrafiltration LC-MS, microplate bioassays, and molecular docking was proposed to screen high-potency enzyme inhibitors from HMs. Using this strategy, the structure-activity relationships (SARs) including binding...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600489

    authors: Song HP,Wang H,Liang JX,Qian C,Wu SQ,Xu WJ,Wu B,Liu XG,Li P,Yang H

    更新日期:2016-12-06 00:00:00

  • The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 Antagonists.

    abstract::Up to 45 % of deaths in developed nations can be attributed to chronic fibroproliferative diseases, highlighting the need for effective therapies. The RGD (Arg-Gly-Asp) integrin αvβ1 was recently investigated for its role in fibrotic disease, and thus warrants therapeutic targeting. Herein we describe the identificati...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900359

    authors: Hatley RJD,Barrett TN,Slack RJ,Watson ME,Baillache DJ,Gruszka A,Washio Y,Rowedder JE,Pogány P,Pal S,Macdonald SJF

    更新日期:2019-07-17 00:00:00

  • Carbon Chain Length Modulates MDA-MB-231 Breast Cancer Cell Killing Mechanisms by Mitochondrially Targeted Aryl-Urea Fatty Acids.

    abstract::Targeting the tumor cell mitochondrion could produce novel anticancer agents. We designed an aryl-urea fatty acid (1 g; 16({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid) that disrupted the mitochondrion and decreased MDA-MB-231 breast cancer cell viability. To optimize the aryl-ureas the prese...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900577

    authors: Murray M,Roseblade A,Chen Y,Bourget K,Rawling T

    更新日期:2020-01-17 00:00:00

  • Analogues of Dehydroacetic Acid as Selective and Potent Agonists of an Ectopic Odorant Receptor through a Combination of Hydrophilic and Hydrophobic Interactions.

    abstract::Identification of potent agonists of odorant receptors (ORs), a major class of G protein-coupled receptors, remains challenging due to complex receptor-ligand interactions. ORs are present in both olfactory and non-chemosensory tissues, indicating roles beyond odor detection that may include modulating physiological f...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600612

    authors: Park BB,Lee N,Kim Y,Jae Y,Choi S,Kang N,Hong YR,Ok K,Cho J,Jeon YH,Lee EH,Byun Y,Koo J

    更新日期:2017-04-06 00:00:00

  • The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.

    abstract::The design of multitarget-directed ligands is a promising strategy for discovering innovative drugs. Here, we report a mechanistic study that clarifies key aspects of the dual inhibition of the fatty acid amide hydrolase (FAAH) and the cyclooxygenase (COX) enzymes by a new multitarget-directed ligand named ARN2508 (2-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500507

    authors: Palermo G,Favia AD,Convertino M,De Vivo M

    更新日期:2016-06-20 00:00:00

  • Structure-activity relationship of trifluoromethyl-containing metallocenes: electrochemistry, lipophilicity, cytotoxicity, and ROS production.

    abstract::We report the synthesis of trifluoromethylated metallocenes (M=Fe, Ru) and related metal-free compounds for comparison of their biological properties with the aim to establish structure-activity relationships toward the anti-proliferative activity of this compound class. All new compounds were comprehensively characte...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402001

    authors: Maschke M,Alborzinia H,Lieb M,Wölfl S,Metzler-Nolte N

    更新日期:2014-06-01 00:00:00

  • Recent advances in the discovery of N-myristoyltransferase inhibitors.

    abstract::N-Myristoyltransferase (NMT) is a cytosolic monomeric enzyme present in eukaryotes such as fungi and protozoa, but is not found in prokaryotes. The attachment of a 14-carbon saturated fatty acid, myristate, from myristoyl-CoA (14:0 CoA) to the N-terminal glycine residue in a specific set of cellular proteins is common...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402174

    authors: Zhao C,Ma S

    更新日期:2014-11-01 00:00:00

  • Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library.

    abstract::A screen of a focused kinase inhibitor library against Trypanosoma brucei rhodesiense led to the identification of seven series, totaling 121 compounds, which showed >50 % inhibition at 5 μm. Screening of these hits in a T. b. brucei proliferation assay highlighted three compounds with a 1H-imidazo[4,5-b]pyrazin-2(3H)...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500300

    authors: Woodland A,Thompson S,Cleghorn LA,Norcross N,De Rycker M,Grimaldi R,Hallyburton I,Rao B,Norval S,Stojanovski L,Brun R,Kaiser M,Frearson JA,Gray DW,Wyatt PG,Read KD,Gilbert IH

    更新日期:2015-11-01 00:00:00

  • Synthesis of anti-microtubule biaryls and preliminary evaluation as vascular-disrupting agents.

    abstract::A series of new dibenzoxepines were synthesized in a straightforward and efficient manner through diastereoselective biaryl Suzuki-Miyaura coupling and Brønsted-acid-mediated cyclodehydration as key steps. The vascular-disrupting potential of these molecules was evaluated with various in vitro assays: inhibition of mi...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800181

    authors: Joncour A,Liu JM,Décor A,Thoret S,Wdzieczak-Bakala J,Bignon J,Baudoin O

    更新日期:2008-11-01 00:00:00

  • Chemistry and biological activity of platinum amidine complexes.

    abstract::Platinum amidine complexes represent a new class of potential antitumor drugs that contain the imino moiety HN=C(sp(2)) bonded to the platinum center. They can be related to the iminoether derivatives, which were recently shown to be the first Pt(II) compounds with a trans configuration endowed with anticancer activit...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201100150

    authors: Michelin RA,Sgarbossa P,Sbovata SM,Gandin V,Marzano C,Bertani R

    更新日期:2011-07-04 00:00:00

  • Caveat Usor: Assessing Differences between Major Chemistry Databases.

    abstract::The three databases of PubChem, ChemSpider, and UniChem capture the majority of open chemical structure records with February 2018 totals of 95, 63, and 154 million, respectively. Collectively, they constitute a massively enabling resource for cheminformatics, chemical biology, and drug discovery. As meta-portals, the...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201700724

    authors: Southan C

    更新日期:2018-03-20 00:00:00

  • Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.

    abstract::Herein we describe the synthesis and conformational analysis of a series of bicyclic thymidine derivatives and their evaluation as inhibitors of thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt), based on previously discovered bicyclic sugar nucleosides. With a K(i) value of 2.3 microm, 1-[3-amin...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600028

    authors: Van Daele I,Munier-Lehmann H,Hendrickx PM,Marchal G,Chavarot P,Froeyen M,Qing L,Martins JC,Van Calenbergh S

    更新日期:2006-10-01 00:00:00

  • Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.

    abstract::Targeted photodynamic therapy is a new promising therapeutic strategy to overcome growing problems in contemporary medicine, such as drug toxicity and drug resistance. A series of erlotinib-zinc(II) phthalocyanine conjugates were designed and synthesized. Compared with unsubstituted zinc(II) phthalocyanine, these conj...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402373

    authors: Zhang FL,Huang Q,Liu JY,Huang MD,Xue JP

    更新日期:2015-02-01 00:00:00

  • Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.

    abstract::A series of novel (R)/(S)-7-(3-alkoxyimino-2-aminomethyl-1-azetidinyl)fluoroquinolone derivatives were synthesized and evaluated for their in vitro antibacterial activity against representative strains. Our results reveal that 12 of the target compounds generally show better activity (MIC: <0.008-0.5 μg mL(-1)) agains...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200210

    authors: Lv K,Sun Y,Sun L,Wei Z,Guo H,Wu J,Liu M

    更新日期:2012-07-01 00:00:00

  • Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.

    abstract::Clostridium difficile infection (CDI) symptoms range from diarrhea to severe toxic megacolon and even death. Due to its rapid acquisition of resistance, C. difficile is listed as an urgent antibiotic-resistant threat, and has surpassed methicillin-resistant Staphylococcus aureus (MRSA) as the most common hospital-acqu...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800240

    authors: Li C,Teng P,Peng Z,Sang P,Sun X,Cai J

    更新日期:2018-07-18 00:00:00

  • Structure-Activity Studies of Bis-O-Arylglycolamides: Inhibitors of the Integrated Stress Response.

    abstract::The integrated stress response comprises multiple signaling pathways for detecting and responding to cellular stress that converge at a single event-the phosphorylation of Ser51 on the α-subunit of eukaryotic translation initiation factor 2 (eIF2α). Phosphorylation of eIF2α (eIF2α-P) results in attenuation of global p...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500483

    authors: Hearn BR,Jaishankar P,Sidrauski C,Tsai JC,Vedantham P,Fontaine SD,Walter P,Renslo AR

    更新日期:2016-04-19 00:00:00

  • Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.

    abstract::An emerging and attractive target for the treatment of Alzheimer's disease is to inhibit the aggregation of beta-amyloid protein (Abeta). We applied the retro-enantio concept to design an N-methylated peptidic inhibitor of the Abeta42 aggregation process. This inhibitor, inrD, as well as the corresponding all-L (inL) ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200900191

    authors: Grillo-Bosch D,Carulla N,Cruz M,Sánchez L,Pujol-Pina R,Madurga S,Rabanal F,Giralt E

    更新日期:2009-09-01 00:00:00

  • N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.

    abstract::From insects to cancer: N-Cyano sulfoximines were evaluated for COX inhibition and antiproliferative activity against a panel of cancer cell lines. The most active compound exhibited potent COX-2 inhibition, some selectivity for COX-2 over COX-1, only slight cytotoxicity towards healthy cells (HaCaT skin cells), and n...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200403

    authors: Park SJ,Baars H,Mersmann S,Buschmann H,Baron JM,Amann PM,Czaja K,Hollert H,Bluhm K,Redelstein R,Bolm C

    更新日期:2013-02-01 00:00:00

  • Discovery of Alternative Chemotherapy Options for Leishmaniasis via Computational Studies of Asteraceae.

    abstract::Leishmaniasis is a complex disease caused by over 20 Leishmania species that primarily affects populations with poor socioeconomic conditions. Currently available drugs for treating leishmaniasis include amphotericin B, paromomycin, and pentavalent antimonials, which have been associated with several limitations, such...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000862

    authors: Herrera-Acevedo C,Perdomo-Madrigal C,Muratov EN,Scotti L,Scotti MT

    更新日期:2020-12-17 00:00:00

  • Asymmetric synthesis and receptor pharmacology of the group II mGlu receptor ligand (1S,2R,3R,5R,6S)-2-amino-3-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid-HYDIA.

    abstract::The asymmetric synthesis and receptor pharmacology of (1S,2R,3R,5R,6S)-2-amino-3-Hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (+)-9 (HYDIA) and a few of its O-alkylated derivatives are described. The key step of the synthesis utilizes Sharpless' asymmetric dihydroxylation (AD-beta) for the kinetic resolution of ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200700226

    authors: Woltering TJ,Adam G,Huguenin P,Wichmann J,Kolczewski S,Gatti S,Bourson A,Kew JN,Richards G,Kemp JA,Mutel V,Knoflach F

    更新日期:2008-02-01 00:00:00

  • Probing Ligand Structure-Activity Relationships in Pregnane X Receptor (PXR): Efavirenz and 8-Hydroxyefavirenz Exhibit Divergence in Activation.

    abstract::Efavirenz (EFV), an antiretroviral that interacts clinically with co-administered drugs via activation of the pregnane X receptor (PXR), is extensively metabolized by the cytochromes P450. We tested whether its primary metabolite, 8-hydroxyEFV (8-OHEFV) can activate PXR and potentially contribute to PXR-mediated drug-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700730

    authors: Narayanan B,Lade JM,Heck CJS,Dietz KD,Wade H,Bumpus NN

    更新日期:2018-04-06 00:00:00

  • The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.

    abstract::Herein we propose the D-Trp-Phe sequence within an inverse type II β-turn as a new kind of pharmacophoric motif for μ-opioid receptor (MOR) cyclopeptide agonists. Initially, we observed that c[Tyr-D-Pro-D-Trp-Phe-Gly] (4), an analogue of endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH₂) lacking the crucial protonatable amino grou...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201100169

    authors: Gentilucci L,Tolomelli A,De Marco R,Spampinato S,Bedini A,Artali R

    更新日期:2011-09-05 00:00:00

  • Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.

    abstract::Metalloproteinases of the astacin family are drawing ever increasing attention as potential drug targets. However, knowledge regarding inhibitors thereof is limited in most cases. Crucial for the development of metalloprotease inhibitors is high selectivity, to avoid side effects brought about by inhibition of off-tar...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800300

    authors: Tan K,Jäger C,Schlenzig D,Schilling S,Buchholz M,Ramsbeck D

    更新日期:2018-08-20 00:00:00

  • Ribonuclease A inhibition by carboxymethylsulfonyl-modified xylo- and arabinopyrimidines.

    abstract::A group of acidic nucleosides were synthesized to develop a new class of ribonuclease A (RNase A) inhibitors. Our recent study on carboxymethylsulfonyl-modified nucleosides revealed some interesting results in RNase A inhibition. This positive outcome triggered an investigation of the role played by secondary sugar hy...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402179

    authors: Datta D,Dasgupta S,Pathak T

    更新日期:2014-09-01 00:00:00

  • Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.

    abstract::A diverse group of proteins, the activities of which are precisely orchestrated during mitosis, have emerged as targets for cancer therapeutics; these include the Aurora kinases (AKs), Polo-like kinases (PLKs), and the kinesin spindle protein (KSP). KSP is essential for the proper separation of spindle poles during mi...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201300228

    authors: Song H,Zhou S,Wang R,Li S

    更新日期:2013-11-01 00:00:00

  • Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.

    abstract::Members of the Eph receptor tyrosine kinase family play essential roles in the pathogenesis of cancer and are therefore promising candidates for molecular imaging by positron emission tomography (PET), for example. In this regard, radiochemical access to novel PET radiotracers derived from potent inhibitors that targe...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200264

    authors: Mamat C,Mosch B,Neuber C,Köckerling M,Bergmann R,Pietzsch J

    更新日期:2012-11-01 00:00:00

  • Drug discovery alliances in India--indications, targets, and new chemical entities.

    abstract::Global pharmaceutical and biotechnology companies have been building increasingly on the skills and services offered by Indian biotech companies through strategic collaborative partnerships and alliances to fuel their in-house discovery and development pipelines. With the exception of generic press releases, however, ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300341

    authors: Differding E

    更新日期:2014-01-01 00:00:00